Abstract: DNA isolates coding for a vascular endothelial cell growth factor may be used to produce the protein via recombinant expression systems. Such protein is useful therapeutically to treat conditions in which a selective action on the vascular endothelial cells, in the absence of excessive connective tissue proliferation, is desirable.

Abstract: DNA isolates coding for a vascular endothelial cell growth factor may be used to produce the protein via recombinant expression systems. Such protein is useful therapeutically to treat conditions in which a selective action on the vascular endothelial cells, in the absence of excessive connective tissue proliferation, is desirable.

Abstract: DNA isolates coding for a vascular endothelial cell growth factor may be used to produce the protein via recombinant expression systems. Such protein is useful therapeutically to treat conditions in which a selective action on the vascular endothelial cells, in the absence of excessive connective tissue proliferation, is desirable.

Abstract: DNA isolates coding for a vascular endothelial cell growth factor may be used to produce the protein via recombinant expression systems. Such protein is useful therapeutically to treat conditions in which a selective action on the vascular endothelial cells, in the absence of excessive connective tissue proliferation, is desirable.

Abstract: A tone detector includes at least one circuit (hereinafter “single phase reference matcher”) that not only performs a convolution of an input signal with a reference signal, but also compares the result of convolution with a threshold to determine if there is a match, and if so drives a signal active indicating that tone is present. If there is no match, another circuit (hereinafter “phase shifter”) delays the reference signal by a fraction (e.g. ⅛) of the measuring period, thereby to introduce a phase shift (e.g. &pgr;/8) between the input signal and the reference signal. The “single phase reference matcher” again performs the just-described operation, this time with a delayed reference signal, and repeats the operation as often as necessary (e.g. eight times) to cycle through the entire measuring period, thereby to ensure that tone (if present in the input signal) is detected irrespective of phase, during one of the operations.

Abstract: Structures and fabrication methods of micromachined all-metal relays on silicon chips are described. The relay comprises a copper blade, electroformed into the lithographically patterned areas, with suitable dimensions of 1 mm.times.2 mm.times.0.01 mm (width.times.length.times.thickness) and a plurality of longitudinal slots to facilitate fabrication of the blade. The relay is actuated by electrostatic force, and no conduction current is required to hold the relay at either "on" or "off" state. Preferably, the relay is used in combination with a suitable arc suppression circuit.

Abstract: Nesting electrical connectors comprising a substrate and a silver-nickel-carbon electrodeposit atop the substrate. The electrodeposit is at least about 0.5 micrometers thick, and comprises about 10 to about 25 atomic percent nickel which is dispersed as a discontinuous phase throughout a continuous phase of the silver and has a Scherrer grain size less than about 5 nanometers. The carbon comprises about 5 to about 15 atomic percent of the deposit and has a non-crystalline graphite structure.

Abstract: A magnetically latching solenoid apparatus is characterized by a non-magnetic armature carrying a permanent magnet having poles aligned with the throw axis of the device. The poles of the magnet are substantially aligned with corresponding pole pieces and define respective variable air gaps therebetween. The apparatus assumes one of two bistable magnetically latched states according to the one of the air gaps across which the magnetic attractive force exceeds the magnetic attractive force across the other of the air gaps. Single or dual winding coils temporally excitable unidirectionally or bidirectionally and, in the case of dual winding coils mutually exclusively or contemporaneously, to cause the latch state to change.

Abstract: A low-energy, long-life, magnetic latching apparatus includes a permanent magnet, an electro-magnet and a bi-stable armature. The magnetization axes of the permanent magnet and the electromagnet are substantially parallel to maximize respective flux coupling. Back-iron is located immediately adjacent the permanent magnet opposite the electro-magnet such that the permanent magnet is intermediate the back-iron and electro-magnet. The armature is arranged to minimize any air-gap between the armature and permanent magnet occasioned by the pivotal movement thereof. The back-iron provides for an increased permanent magnet working point and parallel flux path for electro-magnetic flux.

Abstract: A method and pharmaceutical composition are described for treatment of acne vulgaris which comprises administering to a patient suffering from acne vulgaris an effective amount of a pharmaceutical composition comprising pantothenic acid or a derivative thereof which generates pantothenic acid in the body to form Coenzyme A (CoA), nicotinic acid or a derivative thereof which generates nicotinamide adenine dinucleotide (NAD) or nicotinamide adenine dinucleotide phosphate (NADP) in the body, and biotin, or a mixture thereof.

Abstract: A method and pharmaceutical composition are described for treatment of acne vulgaris which comprises administering to a patient suffering from acne vulgaris an effective amount of a pharmaceutical composition comprising pantothenic acid or a derivative thereof which generates pantothenic acid in the body to form Coenzyme A (CoA), nicotinic acid or a derivative thereof which generates nicotinamide adenine dinucleotide (NAD) or nicotinamide adenine dinucleotide phosphate (NADP) in the body, and biotin, or a mixture thereof.

Abstract: An object of the present invention is to enable an individual to achieve an improvement in the sense of well-being and in the athletic strength resulting in an improvement of the exercise and athletic performance by administering pantothenic acid as a dietary supplement.

Abstract: A method for treating human beings suffering from chronic bronchial asthma, acute rhinitis, disseminated lupus erythematosus, or neurodermatitis which comprises administering to said human being a therapeutically effective amount of pantothenic acid or a derivative.

Abstract: A method is described for weight reduction of an individual dieter which comprises administering pantothenic acid or derivative thereof which will generate pantothenic acid in the body in conjunction with a program of reduced caloric consumption.